{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:36:04Z","timestamp":1791200164501,"version":"4.2.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T00:00:00Z","timestamp":1687046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T00:00:00Z","timestamp":1687046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-CE17-0015"],"award-info":[{"award-number":["ANR-20-CE17-0015"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ASTRA Project"],"award-info":[{"award-number":["ASTRA Project"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Preclinical studies in acute respiratory distress syndrome (ARDS) have suggested that inhaled sevoflurane may have lung-protective effects and clinical trials are ongoing to assess its impact on major clinical outcomes in patients with ARDS. However, the underlying mechanisms of these potential benefits are largely unknown. This investigation focused on the effects of sevoflurane on lung permeability changes after sterile injury and the possible associated mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To investigate whether sevoflurane could decrease lung alveolar epithelial permeability through the Ras homolog family member A (RhoA)\/phospho-Myosin Light Chain 2 (Ser19) (pMLC)\/filamentous (F)-actin pathway and whether the receptor for advanced glycation end-products (RAGE) may mediate these effects. Lung permeability was assessed in RAGE<jats:sup>\u2212\/\u2212<\/jats:sup> and littermate wild-type C57BL\/6JRj mice on days 0, 1, 2, and 4 after acid injury, alone or followed by exposure at 1% sevoflurane. Cell permeability of mouse lung epithelial cells was assessed after treatment with cytomix (a mixture of TNF\u0251, IL-1\u03b2, and IFN\u03b3) and\/or RAGE antagonist peptide (RAP), alone or followed by exposure at 1% sevoflurane. Levels of zonula occludens-1, E-cadherin, and pMLC were quantified, along with F-actin immunostaining, in both models. RhoA activity was assessed in vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In mice after acid injury, sevoflurane was associated with better arterial oxygenation, decreased alveolar inflammation and histological damage, and non-significantly attenuated the increase in lung permeability. Preserved protein expression of zonula occludens-1 and less increase of pMLC and actin cytoskeletal rearrangement were observed in injured mice treated with sevoflurane. In vitro, sevoflurane markedly decreased electrical resistance and cytokine release of MLE-12 cells, which was associated with higher protein expression of zonula occludens-1. Improved oxygenation levels and attenuated increase in lung permeability and inflammatory response were observed in RAGE<jats:sup>\u2212\/\u2212<\/jats:sup> mice compared to wild-type mice, but RAGE deletion did not influence the effects of sevoflurane on permeability indices after injury. However, the beneficial effect of sevoflurane previously observed in wild-type mice on day 1 after injury in terms of higher PaO<jats:sub>2<\/jats:sub>\/FiO<jats:sub>2<\/jats:sub> and decreased alveolar levels of cytokines was not found in RAGE<jats:sup>\u2212\/\u2212<\/jats:sup> mice. In vitro, RAP alleviated some of the beneficial effects of sevoflurane on electrical resistance and cytoskeletal rearrangement, which was associated with decreased cytomix-induced RhoA activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Sevoflurane decreased injury and restored epithelial barrier function in two in vivo and in vitro models of sterile lung injury, which was associated with increased expression of junction proteins and decreased actin cytoskeletal rearrangement. In vitro findings suggest that sevoflurane may decrease lung epithelial permeability through the RhoA\/pMLC\/F-actin pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04253-w","type":"journal-article","created":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T12:01:47Z","timestamp":1687089707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of sevoflurane on lung epithelial permeability in experimental models of acute respiratory distress syndrome"],"prefix":"10.1186","volume":"21","author":[{"given":"Ruoyang","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woodys","family":"Lenga Ma Bonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Leclaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Saint-B\u00e9at","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Theilliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Belville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy","family":"Coupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiko","family":"Blondonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Blanchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8121-1680","authenticated-orcid":false,"given":"Matthieu","family":"Jabaudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,18]]},"reference":[{"key":"4253_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788\u2013800.","journal-title":"JAMA"},{"key":"4253_CR2","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1056\/NEJMra1608077","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377:1904\u20135.","journal-title":"N Engl J Med"},{"key":"4253_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"MA Matthay","year":"2019","unstructured":"Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5:18.","journal-title":"Nat Rev Dis Primers"},{"key":"4253_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet. 2022;400:1145\u201356.","journal-title":"Lancet"},{"key":"4253_CR5","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2020.4031","volume":"323","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in lombardy, italy: early experience and forecast during an emergency response. JAMA. 2020;323:1545\u20136.","journal-title":"JAMA"},{"key":"4253_CR6","doi-asserted-by":"publisher","first-page":"101121","DOI":"10.1016\/j.accpm.2022.101121","volume":"41","author":"F Verdonk","year":"2022","unstructured":"Verdonk F, Feyaerts D, Badenes R, Bastarache JA, Bougl\u00e9 A, Ely W, et al. Upcoming and urgent challenges in critical care research based on COVID-19 pandemic experience. Anaesth Crit Care Pain Med. 2022;41:101121.","journal-title":"Anaesth Crit Care Pain Med."},{"key":"4253_CR7","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.bcp.2009.01.014","volume":"77","author":"R Lucas","year":"2009","unstructured":"Lucas R, Verin AD, Black SM, Catravas JD. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol. 2009;77:1763\u201372.","journal-title":"Biochem Pharmacol"},{"key":"4253_CR8","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","volume":"65","author":"F van Roy","year":"2008","unstructured":"van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65:3756\u201388.","journal-title":"Cell Mol Life Sci"},{"key":"4253_CR9","doi-asserted-by":"publisher","first-page":"12276","DOI":"10.1038\/ncomms12276","volume":"7","author":"B Schlingmann","year":"2016","unstructured":"Schlingmann B, Overgaard CE, Molina SA, Lynn KS, Mitchell LA, Dorsainvil White S, et al. Regulation of claudin\/zonula occludens-1 complexes by hetero-claudin interactions. Nat Commun. 2016;7:12276.","journal-title":"Nat Commun"},{"key":"4253_CR10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1164\/rccm.201512-2435CP","volume":"193","author":"A Jerath","year":"2016","unstructured":"Jerath A, Parotto M, Wasowicz M, Ferguson ND. Volatile anesthetics. Is a new player emerging in critical care sedation? Am J Respir Crit Care Med. 2016;193:1202\u201312.","journal-title":"Am J Respir Crit Care Med."},{"key":"4253_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00134-022-06842-7","volume":"48","author":"JR Beitler","year":"2022","unstructured":"Beitler JR, Talmor D. Volatile anesthetics for ICU sedation: the future of critical care or niche therapy? Intensive Care Med. 2022;48:1413\u20137.","journal-title":"Intensive Care Med"},{"key":"4253_CR12","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.accpm.2022.101133","volume":"41","author":"M Jabaudon","year":"2022","unstructured":"Jabaudon M, Zhai R, Blondonnet R, Bonda WLM. Inhaled sedation in the intensive care unit. Anaesth Crit Care Pain Med. 2022;41:101133.","journal-title":"Anaesth Crit Care Pain Med."},{"key":"4253_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/EJA.0b013e32835f0aa5","volume":"30","author":"C Ferrando","year":"2013","unstructured":"Ferrando C, Aguilar G, Piqueras L, Soro M, Moreno J, Belda FJ. Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: a randomised laboratory study. Eur J Anaesthesiol. 2013;30:455\u201363.","journal-title":"Eur J Anaesthesiol"},{"key":"4253_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/bja\/aes469","volume":"110","author":"K Watanabe","year":"2013","unstructured":"Watanabe K, Iwahara C, Nakayama H, Iwabuchi K, Matsukawa T, Yokoyama K, et al. Sevoflurane suppresses tumour necrosis factor-\u03b1-induced inflammatory responses in small airway epithelial cells after anoxia\/reoxygenation. Br J Anaesth. 2013;110:637\u201345.","journal-title":"Br J Anaesth"},{"key":"4253_CR15","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s00134-012-2610-4","volume":"38","author":"S Fortis","year":"2012","unstructured":"Fortis S, Spieth PM, Lu W-Y, Parotto M, Haitsma JJ, Slutsky AS, et al. Effects of anesthetic regimes on inflammatory responses in a rat model of acute lung injury. Intensive Care Med. 2012;38:1548\u201355.","journal-title":"Intensive Care Med"},{"key":"4253_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2249.2012.04562.x","volume":"168","author":"M Schl\u00e4pfer","year":"2012","unstructured":"Schl\u00e4pfer M, Leutert AC, Voigtsberger S, Lachmann RA, Booy C, Beck-Schimmer B. Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema. Clin Exp Immunol. 2012;168:125\u201334.","journal-title":"Clin Exp Immunol"},{"key":"4253_CR17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00134-016-4429-x","volume":"42","author":"B O\u2019Gara","year":"2016","unstructured":"O\u2019Gara B, Talmor D. Lung protective properties of the volatile anesthetics. Intensive Care Med. 2016;42:1487\u20139.","journal-title":"Intensive Care Med"},{"key":"4253_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1164\/rccm.201604-0686OC","volume":"195","author":"M Jabaudon","year":"2017","unstructured":"Jabaudon M, Boucher P, Imhoff E, Chabanne R, Faure J-S, Roszyk L, et al. Sevoflurane for sedation in acute respiratory distress syndrome. A randomized controlled pilot study. Am J Respir Crit Care Med. 2017;195:792\u2013800.","journal-title":"Am J Respir Crit Care Med."},{"key":"4253_CR19","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3390\/jcm11092500","volume":"11","author":"G Landoni","year":"2022","unstructured":"Landoni G, Belloni O, Russo G, Bonaccorso A, Car\u00e0 G, Jabaudon M. Inhaled sedation for invasively ventilated COVID-19 patients: a systematic review. J Clin Med. 2022;11:2500.","journal-title":"J Clin Med"},{"key":"4253_CR20","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.3390\/jcm11102796","volume":"11","author":"R Blondonnet","year":"2022","unstructured":"Blondonnet R, Simand L-A, Vidal P, Borao L, Bourguignon N, Morand D, et al. Design and rationale of the sevoflurane for sedation in acute respiratory distress syndrome (SESAR) randomized controlled trial. J Clin Med. 2022;11:2796.","journal-title":"J Clin Med"},{"key":"4253_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/ALN.0000000000000742","volume":"123","author":"JA Englert","year":"2015","unstructured":"Englert JA, Macias AA, Amador-Munoz D, Pinilla Vera M, Isabelle C, Guan J, et al. Isoflurane ameliorates acute lung injury by preserving epithelial tight junction integrity. Anesthesiology. 2015;123:377\u201388.","journal-title":"Anesthesiology"},{"key":"4253_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbrc.2015.10.150","volume":"468","author":"Y Huang","year":"2015","unstructured":"Huang Y, Tan Q, Chen R, Cao B, Li W. Sevoflurane prevents lipopolysaccharide-induced barrier dysfunction in human lung microvascular endothelial cells: Rho-mediated alterations of VE-cadherin. Biochem Biophys Res Commun. 2015;468:119\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"4253_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/aas.12098","volume":"57","author":"Y Liu","year":"2013","unstructured":"Liu Y, Gao M, Ma L, Zhang L, Pan N. Sevoflurane alters the expression of receptors and enzymes involved in A\u03b2 clearance in rats. Acta Anaesthesiol Scand. 2013;57:903\u201310.","journal-title":"Acta Anaesthesiol Scand"},{"key":"4253_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159637","volume":"11","author":"JH Zimering","year":"2016","unstructured":"Zimering JH, Dong Y, Fang F, Huang L, Zhang Y, Xie Z. Anesthetic sevoflurane causes Rho-dependent filopodial shortening in mouse neurons. PLoS ONE. 2016;11: e0159637.","journal-title":"PLoS ONE"},{"key":"4253_CR25","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/s00134-012-2624-y","volume":"38","author":"WA Guo","year":"2012","unstructured":"Guo WA, Knight PR, Raghavendran K. The receptor for advanced glycation end products and acute lung injury\/acute respiratory distress syndrome. Intensive Care Med. 2012;38:1588\u201398.","journal-title":"Intensive Care Med"},{"key":"4253_CR26","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1136\/thx.2008.095588","volume":"63","author":"CS Calfee","year":"2008","unstructured":"Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax. 2008;63:1083\u20139.","journal-title":"Thorax"},{"key":"4253_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1164\/rccm.201501-0020OC","volume":"192","author":"M Jabaudon","year":"2015","unstructured":"Jabaudon M, Blondonnet R, Roszyk L, Bouvier D, Audard J, Clairefond G, et al. Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2015;192:191\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"4253_CR28","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s00134-018-5327-1","volume":"44","author":"M Jabaudon","year":"2018","unstructured":"Jabaudon M, Blondonnet R, Pereira B, Cartin-Ceba R, Lichtenstern C, Mauri T, et al. Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data. Intensive Care Med. 2018;44:1388\u201399.","journal-title":"Intensive Care Med"},{"key":"4253_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020;18: e3000411.","journal-title":"PLoS Biol."},{"key":"4253_CR30","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1183\/09031936.00093911","volume":"39","author":"BV Patel","year":"2012","unstructured":"Patel BV, Wilson MR, Takata M. Resolution of acute lung injury and inflammation: a translational mouse model. Eur Respir J. 2012;39:1162\u201370.","journal-title":"Eur Respir J"},{"key":"4253_CR31","doi-asserted-by":"publisher","first-page":"7208","DOI":"10.1038\/s41598-017-07638-2","volume":"7","author":"R Blondonnet","year":"2017","unstructured":"Blondonnet R, Audard J, Belville C, Clairefond G, Lutz J, Bouvier D, et al. RAGE inhibition reduces acute lung injury in mice. Sci Rep. 2017;7:7208.","journal-title":"Sci Rep"},{"key":"4253_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.accpm.2020.04.002","volume":"39","author":"F Blanchard","year":"2020","unstructured":"Blanchard F, Perbet S, James A, Verdonk F, Godet T, Bazin J-E, et al. Minimal alveolar concentration for deep sedation (MAC-DS) in intensive care unit patients sedated with sevoflurane: a physiological study. Anaesth Crit Care Pain Med. 2020;39:429\u201334.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"4253_CR33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1165\/rcmb.2021-0531ST","volume":"66","author":"HS Kulkarni","year":"2022","unstructured":"Kulkarni HS, Lee JS, Bastarache JA, Kuebler WM, Downey GP, Albaiceta GM, et al. Update on the features and measurements of experimental acute lung injury in animals: an official American Thoracic Society Workshop Report. Am J Respir Cell Mol Biol. 2022;66:e1-14.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4253_CR34","doi-asserted-by":"publisher","first-page":"L975","DOI":"10.1152\/ajplung.00242.2013","volume":"306","author":"A Goolaerts","year":"2014","unstructured":"Goolaerts A, Pellan-Randrianarison N, Larghero J, Vanneaux V, Uzunhan Y, Gille T, et al. Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury. Am J Physiol Lung Cell Mol Physiol. 2014;306:L975\u201385.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4253_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.bbrc.2017.11.058","volume":"495","author":"JL Kuck","year":"2018","unstructured":"Kuck JL, Bastarache JA, Shaver CM, Fessel JP, Dikalov SI, May JM, et al. Ascorbic acid attenuates endothelial permeability triggered by cell-free hemoglobin. Biochem Biophys Res Commun. 2018;495:433\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"4253_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44:725\u201338.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4253_CR37","doi-asserted-by":"publisher","first-page":"11659","DOI":"10.3390\/ijms231911659","volume":"23","author":"W Lenga Ma Bonda","year":"2022","unstructured":"Lenga Ma Bonda W, Fournet M, Zhai R, Lutz J, Blondonnet R, Bourgne C, et al. Receptor for advanced glycation end-products promotes activation of alveolar macrophages through the NLRP3 Inflammasome\/TXNIP axis in acute lung injury. Int J Mol Sci. 2022;23:11659.","journal-title":"Int J Mol Sci."},{"key":"4253_CR38","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/ALN.0b013e3181bdf857","volume":"111","author":"S Voigtsberger","year":"2009","unstructured":"Voigtsberger S, Lachmann RA, Leutert AC, Schl\u00e4pfer M, Booy C, Reyes L, et al. Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury. Anesthesiology. 2009;111:1238\u201348.","journal-title":"Anesthesiology"},{"key":"4253_CR39","doi-asserted-by":"publisher","first-page":"L731","DOI":"10.1152\/ajplung.00309.2014","volume":"308","author":"K Brune","year":"2015","unstructured":"Brune K, Frank J, Schwingshackl A, Finigan J, Sidhaye VK. Pulmonary epithelial barrier function: some new players and mechanisms. Am J Physiol Lung Cell Mol Physiol. 2015;308:L731\u201345.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4253_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.27","volume":"47","author":"J Chai","year":"2015","unstructured":"Chai J, Long B, Liu X, Li Y, Han N, Zhao P, et al. Effects of sevoflurane on tight junction protein expression and PKC-\u03b1 translocation after pulmonary ischemia-reperfusion injury. Exp Mol Med. 2015;47: e167.","journal-title":"Exp Mol Med"},{"key":"4253_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116916","volume":"239","author":"X Yang","year":"2019","unstructured":"Yang X, Zheng Y-T, Rong W. Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer in vitro and in vivo via inactivating Ras\/Raf\/MEK\/ERK signaling. Life Sci. 2019;239: 116916.","journal-title":"Life Sci"},{"key":"4253_CR42","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1091\/mbc.e07-04-0315","volume":"18","author":"SN Samarin","year":"2007","unstructured":"Samarin SN, Ivanov AI, Flatau G, Parkos CA, Nusrat A. Rho\/Rho-associated kinase-II signaling mediates disassembly of epithelial apical junctions. Mol Biol Cell. 2007;18:3429\u201339.","journal-title":"Mol Biol Cell"},{"key":"4253_CR43","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2353\/ajpath.2010.100168","volume":"177","author":"AI Ivanov","year":"2010","unstructured":"Ivanov AI, Parkos CA, Nusrat A. Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol. 2010;177:512\u201324.","journal-title":"Am J Pathol"},{"key":"4253_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/0394632016638346","volume":"29","author":"J Li","year":"2016","unstructured":"Li J, Yuan T, Zhao X, Lv G-Y, Liu H-Q. Protective effects of sevoflurane in hepatic ischemia-reperfusion injury. Int J Immunopathol Pharmacol. 2016;29:300\u20137.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4253_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184973","volume":"12","author":"T Restin","year":"2017","unstructured":"Restin T, Kajdi M-E, Schl\u00e4pfer M, Roth Z\u2019graggen B, Booy C, Dumrese C, et al. Sevoflurane protects rat brain endothelial barrier structure and function after hypoxia-reoxygenation injury. PLoS ONE. 2017;12: e0184973.","journal-title":"PLoS ONE."},{"key":"4253_CR46","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/21541248.2017.1339767","volume":"10","author":"MCA Pronk","year":"2019","unstructured":"Pronk MCA, van Bezu JSM, van Nieuw Amerongen GP, van Hinsbergh VWM, Hordijk PL. RhoA, RhoB and RhoC differentially regulate endothelial barrier function. Small GTPases. 2019;10:466\u201384.","journal-title":"Small GTPases"},{"key":"4253_CR47","first-page":"3","volume":"18","author":"R Zhai","year":"2022","unstructured":"Zhai R, Bonda WLM, Matute-Bello G, Jabaudon M. From preclinical to clinical models of acute respiratory distress syndrome. Signa Vitae. 2022;18:3\u201314.","journal-title":"Signa Vitae"},{"key":"4253_CR48","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1007\/s00134-020-06307-9","volume":"46","author":"G Chanques","year":"2020","unstructured":"Chanques G, Constantin J-M, Devlin JW, Ely EW, Fraser GL, G\u00e9linas C, et al. Analgesia and sedation in patients with ARDS. Intensive Care Med. 2020;46:2342\u201356.","journal-title":"Intensive Care Med"},{"key":"4253_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.accpm.2017.08.006","volume":"37","author":"M Jabaudon","year":"2018","unstructured":"Jabaudon M, Blondonnet R, Audard J, Fournet M, Godet T, Sapin V, et al. Recent directions in personalised acute respiratory distress syndrome medicine. Anaesth Crit Care Pain Med. 2018;37:251\u20138.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"4253_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40635-022-00435-w","volume":"10","author":"LDJ Bos","year":"2022","unstructured":"Bos LDJ, Laffey JG, Ware LB, Heijnen NFL, Sinha P, Patel B, et al. Towards a biological definition of ARDS: are treatable traits the solution? Intensive Care Med Exp. 2022;10:8.","journal-title":"Intensive Care Med Exp"},{"key":"4253_CR51","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S2213-2600(22)00294-6","volume":"10","author":"KD Wick","year":"2022","unstructured":"Wick KD, Aggarwal NR, Curley MAQ, Fowler AA 3rd, Jaber S, Kostrubiec M, et al. Opportunities for improved clinical trial designs in acute respiratory distress syndrome. Lancet Respir Med. 2022;10:916\u201324.","journal-title":"Lancet Respir Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04253-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04253-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04253-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T13:01:27Z","timestamp":1687093287000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04253-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4253"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04253-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,18]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mouse experiments were approved by the Animal Ethics Committee of the French Minist\u00e8re de l\u2019Education Nationale, de l\u2019Enseignement Sup\u00e9rieur et de la Recherche (approval number CE 67\u201312; December 4, 2012). All experiments were performed following relevant guidelines and regulations for animal and cell experimentations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No competing interests, other source of financial support, corporate involvement, patent holdings, etc. is to be declared for all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"397"}}